SQI Diagnostics, Inc. is a life sciences company that develops and commercializes proprietary technologies and products for advanced multiplexing diagnostics. The firm is focused on developing the business units targeting organ transplant, autoimmune disease, and serological testing. It involves in commercializing its developmental COVID-19 antibody test kit, and also the RALI-Dx and RALI-fast Point-of-Care tests to triage COVID-19 patients for respiratory distress. The company was founded by Peter Lea in 1999 and is headquartered in Toronto, Canada.
Industry:
Medical Specialties